Heidi Hagen
Director · Obsidian Therapeutics, Inc.
IndividualSelling only3 10b5-1 trades
- 2024
- Aug 5, 2026
- 4
Other insiders active in the same sector
No other insider has filed at Heidi Hagen's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- David Cordani - $60.11M in CI purchases and sales in the last 12 months
- AI DMI LLC - $59.87M in IRON purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $59.04M in SGP purchases and sales in the last 12 months
- Mark A. Goldsmith - $56.99M in RVMD purchases and sales in the last 12 months
- Peter A. Thompson - $55.67M in SION purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $55.67M in SION purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Heidi Hagen?
Heidi Hagen is a corporate insider, tracked as Director of Obsidian Therapeutics, Inc. (OBX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Heidi Hagen submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Heidi Hagen been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($486K) across all tracked filings.
